Home >
News >
Scholarships are available: 22nd ANNUAL JOHN GOLDMAN CONFERENCE ON CHRONIC MYELOID LEUKEMIA: BIOLOGY AND THERAPY
Scholarships are available: 22nd ANNUAL JOHN GOLDMAN CONFERENCE ON CHRONIC MYELOID LEUKEMIA: BIOLOGY AND THERAPY
September 01, 2020
22nd ANNUAL JOHN GOLDMAN CONFERENCE ON
CHRONIC MYELOID LEUKEMIA:
BIOLOGY AND THERAPY
October 1-4, 2020
MOVING ONLINE!
Chairs: Jorge Cortes, Tim P. Hughes, Daniela S. Krause
Co-organizers: Ravi Bhatia, Tim Brümmendorf, Mhairi Copland, Michael Deininger,
Olivier Hantschel, François-Xavier Mahon, Danilo Perrotti, Jerry Radich, Delphine Réa
Advisory Committee: Jane Apperley, Susan Branford, Carlo Gambacorti-Passerini, François Guilhot, Rüdiger Hehlmann, Pierre Laneuville, Giuseppe Saglio, Charles Schiffer, Simona Soverini, Peter Valent, Rick Van Etten
ESH SCHOLARSHIP FUND
LEUKAEMIA UK INTERNATIONAL SCHOLARSHIPS are available!
INFORMATION AND APPLICATION FORM
The ESH Scholarship Fund is a multi-sponsored project designed to support access to new biological and clinical data in the context of lifelong learning in Haematology.
ESH independently ensures all scientific peer review and selection procedures.
ESH is also independently responsible for all administrative aspects of the Fund.
Deadline for applications: September 7th, 2020
This Call for Applications is made thanks to a funding support from
to the ESH Scholarship Fund
- ELIGIBILITY CRITERIA:
- Fully trained, with a maximum of 4 years of experience since your first junior faculty appointment
- or residents and PhD candidates
- SCHOLARSHIPS WILL COVER:
- Registration fee to the CML E-Conference
Clich
here to download and complete the application form
ABOUT THE CONFERENCE:
In view of continuing COVID-19 related challenges and uncertainties, this year's 22nd John Goldman International Conference on Chronic Myeloid Leukemia: Biology and Therapy will take place as a virtual event.
Please note that it will begin one day earlier than initially planned, extending from October 1-4, 2020.
ABOUT THE PROGRAM:
Speakers at this meeting will present the newest, often unpublished data relating to the (1) Biology of CML including the origin of BCR-ABL1, signal transduction, basis of disease progression, action of tyrosine kinase inhibitors and mechanisms underlying resistance to TKI, and (2) aspects of treatment including prediction and definition of responses, drugs used in combination, modern diagnostics and molecular monitoring, targeting residual stem cells, approaches to cure and treatment free remission.
The program will include:
- John Goldman Prize Lecture : Jane Apperley (London)
- Janet Rowley Prize Lecture : Ravi Bhatia (Birmingham, USA)
- iCMLf Prize Lecture : Sabira Kurtovic (Sarajevo)
- Tessa Holyoake Memorial Lecture : Ulrich Steidl (New York)
- Special Introductory Lecture : John Dick (Toronto)
- Special Lectures : Tannishtha Reya (San Diego), Melissa Ilardo (Salt Lake City), Bethan Psaila (Oxford)
- Workshop for Non-Clinical Ccientists on Proteomics and Secretomics
- Chairs: Oliver Hantschel (Marburg), Vignir Helgason (Glasgow)
- Speakers : Anthony Whetton (Manchester), Sara Zanivan (Glasgow), Oliver Schilling (Freiburg)
- Workshop for Non-Clinical Scientists on Artifical Intelligence and Machine Learning
- Chairs: Michael Deininger (Salt Lake City), Daniela Krause (Frankfurt)
- Speakers : Timm Schroeder (Basel), Andrew Janowczyk (Cleveland)
- Special Symposium 2020 on Oncoimmunology in Hematologic Malignancies
- Speakers: David Scheinberg (New York), Saar Gill (Philadelphia), Xianxin Hua (Philadelphia), Justin Kline (Chicago), Roland Walter (Seattle)
- Keynote Lectures
- Oral Communications selected from submitted abstracts
- Meet-the-Expert Sessions
- Clinical and Biology Mentored Poster Walks
and
- The ESH International John Goldman Research Award presentation 2020 to Vaidehi KRISHNAN (Singapore)
MAIN TOPICS:
- Stem Cells and the microenvironment
- Molecular biology and new targets
- Proteomics and Secretomics
- Artificial Intelligence and Machine Learning
- Mechanisms of resistance and disease progression
- Biomarkers
- Immunology and Inflammation
- Therapeutic interventions
- Immunotherapy
- Treatment free remission
- Safety and patient reported outcomes
- Clinical trial design
- The new ELN recommendations
- New drugs in development
|
The E-Conference platform is already open.
Visit it now and make yourself
at home!
|
|
TIMING OF THE SCIENTIFIC PROGRAM:
Participants will be joining us from all over the world and from different time zones. To make sure that everyone has access to the full scientific programme at a convenient hour, registration will allow participants to join both the LIVE PROGRAM
and the PROGRAM ON DEMAND.
THE LIVE PROGRAM:
Oct. 4-8, 2020, CEST time.
The whole programme will be broadcast live. It will be streamed live CEST time, as indicated. It will include lectures, roundtable discussions, Meet the Expert sessions, interactive panel discussions and Q&A periods, and E-Mentored Poster Walks.
Consult the live program
HERE
THE PROGAM ON DEMAND:
Sept. 21-Oct. 14, 2020
It will initially include the pre-recorded components of the scientific program. It will be progressively enriched by the meeting’s live, interactive components which will be recorded real time during the meeting.
E-POSTERS:
Sept. 21-Oct. 14, 2020
The Poster Hall will also remain open until October 14, 2020.
The Mentored Poster Walk scheduled in the LIVE PROGRAM will also become available in the PROGRAM ON DEMAND.
SATELLITE SYMPOSIA LIVE AND ON DEMAND:
Symposia organized independently by our corporate partners in conjunction with the ESH meeting will also be available both Live and On Demand as described above, from Sept. 21 until Oct. 14, 2020.
VIRTUAL EXHIBITION:
Sept. 21-Oct.214,2020
We invite you to visit the e-Exhibition area as of September 21.
Our corporate partners will be pleased to welcome and chat with you.
With the support of*:
Emerald Conference Partners
********
Ruby Conference Partner
********
*ESH conference programmes are developed in strict scientific independence
with no input from corporate sponsors.
